Nautilus Biotechnology (NAUT) Institutional Ownership $0.69 -0.02 (-2.21%) Closing price 04:00 PM EasternExtended Trading$0.69 0.00 (0.00%) As of 07:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Nautilus Biotechnology (NASDAQ:NAUT)CurrentInstitutional OwnershipPercentage50.71%Number ofInstitutional Buyers(last 12 months)33TotalInstitutional Inflows(last 12 months)$3.52MNumber ofInstitutional Sellers(last 12 months)12TotalInstitutional Outflows(last 12 months)$2.21M Get NAUT Insider Trade Alerts Want to know when executives and insiders are buying or selling Nautilus Biotechnology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data NAUT Institutional Buying and Selling by Quarter Nautilus Biotechnology Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2025 Corient Private Wealth LLC435,350$316K0.0%+860.0%0.345% 8/15/2025 Bridgeway Capital Management LLC125,000$91K0.0%+150.0%0.099% 8/14/2025 Jane Street Group LLC290,369$210K0.0%+304.1%0.230% 8/14/2025 Qube Research & Technologies Ltd62,138$45K0.0%N/A0.049% 8/12/2025 XTX Topco Ltd66,194$48K0.0%+86.2%0.052% 8/8/2025 Geode Capital Management LLC553,602$401K0.0%-51.9%0.438% 8/1/2025 Y Intercept Hong Kong Ltd224,456$163K0.0%N/A0.178% 7/24/2025 Callan Family Office LLC48,894$35K0.0%N/A0.039% 7/22/2025 Clarius Group LLC1,060,460$769K0.0%+22.4%0.841% 7/9/2025 Presidio Capital Management LLC34,664$25K0.0%+246.6%0.027% Get the Latest News and Ratings for NAUT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Nautilus Biotechnology and its competitors with MarketBeat's FREE daily newsletter. 6/27/2025 Goldman Sachs Group Inc.171,787$148K0.0%-12.2%0.136% 5/21/2025 Acadian Asset Management LLC61,735$51K0.0%+468.3%0.049% 5/19/2025 Jane Street Group LLC71,857$62K0.0%-33.8%0.057% 5/16/2025 Goldman Sachs Group Inc.171,787$148K0.0%-12.2%0.136% 5/16/2025 Jacobs Levy Equity Management Inc.225,098$194K0.0%N/A0.178% 5/16/2025 Bain Capital Life Sciences Investors LLC1,072,421$923K0.1%-39.0%0.850% 5/12/2025 Nuveen LLC193,591$167K0.0%N/A0.153% 5/12/2025 Fayez Sarofim & Co45,000$39K0.0%N/A0.036% 5/9/2025 Deutsche Bank AG54,839$47K0.0%+145.2%0.043% 5/8/2025 XTX Topco Ltd35,553$31K0.0%N/A0.028% 5/1/2025 Sentinel Trust Co. LBA280,000$241K0.0%+9.8%0.222% 4/18/2025 Clarius Group LLC866,586$746K0.0%+36.1%0.687% 2/17/2025 Squarepoint Ops LLC26,324$44K0.0%N/A0.021% 2/17/2025 Wexford Capital LP325,239$546K0.1%+42.4%0.259% 2/17/2025 Millennium Management LLC37,704$63K0.0%N/A0.030% 2/17/2025 Cubist Systematic Strategies LLC20,256$34K0.0%N/A0.016% 2/17/2025 Citadel Advisors LLC220,220$370K0.0%+171.4%0.175% 2/17/2025 Bank of America Corp DE49,419$83K0.0%+37.1%0.039% 2/17/2025 Alyeska Investment Group L.P.253,468$426K0.0%-42.5%0.202% 2/14/2025 Jane Street Group LLC108,545$182K0.0%+188.1%0.086% 2/14/2025 Northern Trust Corp474,821$798K0.0%-6.4%0.378% 2/14/2025 Hsbc Holdings PLC55,184$92K0.0%+182.5%0.044% 2/14/2025 Bain Capital Life Sciences Investors LLC1,759,000$2.96M0.3%-12.1%1.401% 2/14/2025 Dimensional Fund Advisors LP770,353$1.29M0.0%+11.3%0.614% 2/13/2025 Barclays PLC125,204$210K0.0%+17.9%0.100% 2/13/2025 Renaissance Technologies LLC250,221$420K0.0%+61.7%0.199% 2/13/2025 ArchPoint Investors606,133$1.02M0.3%-1.3%0.483% 2/12/2025 Geode Capital Management LLC1,142,542$1.92M0.0%+0.6%0.910% 2/12/2025 JPMorgan Chase & Co.145,937$245K0.0%+309.9%0.116% 2/11/2025 Virtu Financial LLC16,604$28K0.0%N/A0.013% Everyone’s watching Nvidia right now. Here’s why I’m excited. (Ad)So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯 We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer.🎯 Click here to watch the video and get the free ticker XGPT just flagged.2/6/2025 Charles Schwab Investment Management Inc.115,231$194K0.0%-16.2%0.092% 2/5/2025 Sentinel Trust Co. LBA255,000$428K0.0%-19.0%0.203% 1/30/2025 Palumbo Wealth Management LLC28,475$48K0.0%+45.4%0.023% 1/17/2025 SG Americas Securities LLC27,483$46K0.0%+56.3%0.022% 11/19/2024 Barclays PLC106,174$303K0.0%+79.6%0.085% 11/15/2024 Barclays PLC106,174$303K0.0%+79.6%0.085% 11/15/2024 Y Intercept Hong Kong Ltd12,404$35K0.0%-48.1%0.010% 11/15/2024 Jane Street Group LLC37,682$107K0.0%-39.9%0.030% 11/15/2024 Wexford Capital LP228,350$651K0.2%+9.6%0.182% 11/15/2024 State Street Corp932,931$2.66M0.0%-0.9%0.743% 11/15/2024 Clearline Capital LP144,187$411K0.0%-12.1%0.115% 11/14/2024 MetLife Investment Management LLC30,613$87K0.0%N/A0.024% 11/13/2024 The Manufacturers Life Insurance Company23,612$67K0.0%N/A0.019% 10/25/2024China Universal Asset Management Co. Ltd.24,121$69K0.0%+63.9%0.019% 10/3/2024 SG Americas Securities LLC17,579$50K0.0%N/A0.014% 8/16/2024 Clearline Capital LP164,073$384K0.0%-2.9%0.131% 8/12/2024 Hsbc Holdings PLC17,468$41K0.0%-31.6%0.014% 8/9/2024 Renaissance Technologies LLC140,100$328K0.0%+11.2%0.112% 8/9/2024 Dimensional Fund Advisors LP574,844$1.35M0.0%+19.8%0.459% 7/11/2024 Clarius Group LLC636,532$1.49M0.1%+2.7%0.508% 5/15/2024 Price T Rowe Associates Inc. MD16,078$48K0.0%+35.8%0.013% 5/10/2024 Vanguard Group Inc.2,859,402$8.41M0.0%+1.0%2.283% 5/7/2024 SG Americas Securities LLC20,209$59K0.0%-29.4%0.016% 4/29/2024China Universal Asset Management Co. Ltd.24,076$71K0.0%+66.6%0.019% 2/26/2024 Perceptive Advisors LLC12,594,211$37.66M0.8%+38.2%10.079% 2/13/2024Lake Street Advisors Group LLC22,762$68K0.0%-17.5%0.018% 2/6/2024 Axxcess Wealth Management LLC10,000$30K0.0%N/A0.008% 2/5/2024 Vanguard Capital Wealth Advisors40,000$120K0.1%-13.0%0.032% 1/24/2024China Universal Asset Management Co. Ltd.14,452$43K0.0%+351.1%0.012% 1/12/2024 SG Americas Securities LLC28,606$86K0.0%+27.9%0.023% 1/12/2024 Presidio Capital Management LLC10,000$30K0.0%N/A0.008% 11/13/2023 Federated Hermes Inc.9,133$29K0.0%N/A0.007% 11/8/2023 Kestra Private Wealth Services LLC11,897$38K0.0%N/A0.010% 11/1/2023 Vanguard Capital Wealth Advisors46,000$145K0.1%-25.2%0.037% 10/24/2023 Bank of New York Mellon Corp153,249$484K0.0%+2.5%0.123% 10/13/2023 SG Americas Securities LLC22,372$71K0.0%N/A0.018% 8/3/2023 Sentinel Trust Co. LBA280,000$1.08M0.1%+80.6%0.224% 7/21/2023 PDS Planning Inc10,455$40K0.0%N/A0.008% 7/17/2023 Vanguard Capital Wealth Advisors59,000$228K0.2%-21.9%0.047% 5/5/2023 Sentinel Trust Co. LBA155,000$429K0.1%-16.2%0.124% 4/21/2023 Vanguard Capital Wealth Advisors75,500$209K0.2%+228.3%0.060% 4/17/2023 Clarius Group LLC597,972$1.66M0.1%+1.8%0.479% 2/15/2023 Nantahala Capital Management LLC289,845$522K0.0%-55.8%0.232% 2/14/2023 Susquehanna International Group LLP23,818$43K0.0%-35.9%0.019% 2/7/2023 Sentinel Trust Co. LBA185,000$333K0.1%-14.0%0.148% 1/25/2023 Clarius Group LLC587,305$1.06M0.1%+16.4%0.471% 11/14/2022 RTW Investments LP600,000$1.27M0.0%-45.5%0.481% 11/10/2022 Nantahala Capital Management LLC655,338$1.39M0.1%-16.5%0.525% 11/7/2022 Jump Financial LLC15,000$32K0.0%-25.0%0.012% 8/15/2022 Clearline Capital LP262,360$706K0.1%+6.3%0.210% Market Panic: Trump Just Dropped a Bomb on Your Stocks (Ad)tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.Don't wait for the next drop to wipe you out. Get the FREE Guide Before Markets Open Tomorrow8/15/2022 Nantahala Capital Management LLC784,798$2.11M0.1%-12.2%0.630% 8/12/2022 Affinity Asset Advisors LLC466,607$1.26M0.5%-16.5%0.374% 8/11/2022 Crown Advisors Management Inc.250,000$672K0.6%N/A0.201% 8/10/2022 Clarius Group LLC504,404$1.36M0.1%+18.1%0.405% 8/4/2022 Brighton Jones LLC44,244$119K0.0%N/A0.036% 7/29/2022 SG Americas Securities LLC19,207$52K0.0%N/A0.015% 7/25/2022 Strs Ohio11,100$29K0.0%N/A0.009% 7/12/2022 FNY Investment Advisers LLC25,600$68K0.1%-19.1%0.021% 5/16/2022 Clearline Capital LP246,713$1.07M0.1%+8.0%0.198% 5/16/2022 Tikvah Management LLC1,488,895$6.46M2.1%+20.9%1.196% (Data available from 1/1/2016 forward) NAUT Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of NAUT shares? During the previous two years, 50 institutional investors and hedge funds held shares of Nautilus Biotechnology. The most heavily invested institutionals were Perceptive Advisors LLC ($37.66M), Vanguard Group Inc. ($8.41M), State Street Corp ($2.66M), Dimensional Fund Advisors LP ($1.29M), ArchPoint Investors ($1.02M), Bain Capital Life Sciences Investors LLC ($923K), and Northern Trust Corp ($798K).Learn more on Nautilus Biotechnology's institutional investors. What percentage of Nautilus Biotechnology's stock is owned by institutional investors? 50.71% of Nautilus Biotechnology's stock is owned by institutional investors. Learn more on NAUT's institutional investor holdings. Which institutional investors have been buying Nautilus Biotechnology's stock? Of the 40 institutional investors that purchased Nautilus Biotechnology's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Perceptive Advisors LLC ($3.48M), Clarius Group LLC ($440.59K), Corient Private Wealth LLC ($390K), Jane Street Group LLC ($289.38K), Jacobs Levy Equity Management Inc. ($225.10K), Y Intercept Hong Kong Ltd ($224.46K), and Nuveen LLC ($193.59K). How much institutional buying is happening at Nautilus Biotechnology? Institutional investors have bought a total of 3,086,920 shares in the last 24 months. This purchase volume represents approximately $3.52M in transactions. Which of Nautilus Biotechnology's major shareholders have been selling company stock? Of the 12 institutional investors that sold Nautilus Biotechnology's stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Bain Capital Life Sciences Investors LLC ($927.58K), Geode Capital Management LLC ($597.42K), Alyeska Investment Group L.P. ($187.55K), Jane Street Group LLC ($61.71K), Sentinel Trust Co. LBA ($60K), Goldman Sachs Group Inc. ($47.82K), and Northern Trust Corp ($32.70K). How much institutional selling is happening at Nautilus Biotechnology? Institutional investors have sold a total of 1,984,867 shares in the last 24 months. This volume of shares sold represents approximately $2.21M in transactions. Related Companies FEIM Institutional Ownership MASS Institutional Ownership QSI Institutional Ownership QTRX Institutional Ownership KEQU Institutional Ownership OWLT Institutional Ownership SEER Institutional Ownership RPID Institutional Ownership PRE Institutional Ownership INTT Institutional Ownership This page (NASDAQ:NAUT) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersNVIDIA's Worst Nightmare?$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...The Oxford Club | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredWhat Are Some Strategies to Help Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredTrump’s national nightmare is hereAI is no longer just about chatbots — it’s becoming the backbone of the global economy. While U.S. firms push ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nautilus Biotechnology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nautilus Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access